Pinnacle Financial Group, Inc.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Buy
+6,483
New +$1.02M 0.1% 168

Other funds holding XBI

Pinnacle Financial Group, Inc.'s XBI Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 6,483 shares worth $1.02M. The stake represents 0.1% of the portfolio and ranks #168 among its holdings.

952 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 6,483 shares of State Street SPDR S&P Biotech ETF worth $1.02M as of Q3 2026.
  • State Street SPDR S&P Biotech ETF was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.1% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #168 holding.
  • 952 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.